Clinical Trial

A Clinical Trial of Adsorbed Cell-free DPT Vaccine (5-component) (for People Aged 6 Years and Above)

Completed Phase 1
View on ClinicalTrials.gov →
Summary
Pertussis is an acute respiratory infectious disease caused by Bordetella pertussis, diphtheria is an acute upper respiratory infectious disease caused by Gram-positive Corynebacterium diphtheriae, and tetanus is a highly fatal disease caused by Clostridium tetani infection. Currently, there is no clinical trial registration of Diphtheria, tetanus, and pertussis (DPT) vaccine applicable to ≥6 years of age in China, therefore, the five-component acellular DPT combination vaccine developed by our research has a promising future.
Protocol Amendment History 2 changes
critical Trial completed 2026-08-08
minor Completion moved earlier: 2025-09-28 -> 2025-03-11 2026-08-08
Trial Details
NCT Number NCT06056050
Lead Sponsor CanSino Biologics Inc.
Conditions Diphtheria, Tetanus, Pertussis
Enrollment 180 participants
Start Date 2023-12-06
Primary Completion 2024-04-13 (estimated)
Study Completion 2025-03-11 (estimated)
Updated on ClinicalTrials.gov 2026-08-07